SCHEMBL30001410

SCHEMBL30001410

NC(=O)c1scc2cccnc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 2/20 0.53
LIMK1 P53667 2/20 0.51
IKBKB O14920 2/20 0.44
CHUK O15111 1/20 0.44
KDM4E B2RXH2 4/20 0.41
MMP2 P08253 2/20 0.41
TSHR P16473 2/20 0.41
CYP3A4 P08684 2/20 0.41
ALOX15 P16050 2/20 0.41
MAPT P10636 2/20 0.41
GMNN O75496 1/20 0.41
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
HSP90AA1 P07900 1/20 0.41
CYP2D6 P10635 1/20 0.41
MMP9 P14780 1/20 0.41
NFKB1 P19838 1/20 0.41
MMP8 P22894 1/20 0.41
CCR1 P32246 1/20 0.41
THPO P40225 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23413589 0.84 ALDH1A1 (0.47) PARP1KDM4EMMP2TSHRCYP3A4
SCHEMBL23413127 0.79 ALOX15 (0.47) PARP1KDM4ETSHRALOX15MAPT
SCHEMBL30122238 0.72 LIMK1 (0.51) PARP1LIMK1IKBKBCHUKKDM4E
SCHEMBL5187759 0.71 LIMK1 (0.46) PARP1LIMK1IKBKBCHUKKDM4E
SCHEMBL29959688 0.69 PARP1 (1.00) PARP1KDM4EMMP2TSHRLMNA
SCHEMBL460456 0.69 PARP1 (1.00) PARP1KDM4EMMP2TSHRLMNA
SCHEMBL29923346 0.69 PARP1 (1.00) PARP1KDM4EMMP2TSHRLMNA
SCHEMBL29654023 0.69 LIMK1 (0.51) PARP1LIMK1IKBKBCHUKKDM4E
SCHEMBL19555042 0.69 PARP1 (0.53) PARP1LIMK1IKBKBCHUKKDM4E
SCHEMBL30844941 0.69 PARP1 (0.53) PARP1LIMK1IKBKBCHUKKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022255888-A1 TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN CAPTOR THERAPEUTICS S.A. (PL) 2022-12-08 WO disclosed